Senator continues strong support of women’s freedom to make their own decisions about their health and futures
WASHINGTON – Arizona senior Senator Kyrsten Sinema backed a Senate resolution in support of the U.S. Food and Drug Administration’s (FDA) approval of mifepristone, a drug used by women and their doctors to manage reproductive health care, including miscarriage care. The resolution follows news last month that the U.S. Supreme Court will review a lower court ruling that would limit access to mifepristone.
“A woman’s health care decisions should be made between her, her doctor, and her family. We’re continuing to support science-based approaches that protect Arizona women’s freedom to make their own decisions about their futures,” said Sinema.
Last year, Sinema submitted an amicus brief in the Alliance for Hippocratic Medicine v. FDA case supporting the FDA’s scientific and evidence-based approval of mifepristone. Mifepristone is one of the two medications typically used in reproductive and miscarriage care, which has been FDA-approved and safely used for over 20 years.
Sinema, along with Republican Senators Lisa Murkowski (Alaska) and Susan Collins (Maine) and Democratic Senator Tim Kaine (Va.), introduced the Reproductive Freedom For All Act – bipartisan legislation protecting women’s freedom to make their own health care decisions by enacting the core protections of Roe v. Wade and related Supreme Court cases into law.